Orthobiologics Market to Reach $6.87 Bn, Globally, by 2025 at 4.3% CAGR

Orthobiologics Market by Product (Demineralized Bone Matrix {DBM}, Allograft, Bone Morphogenetic Protein {BPM}, Viscosupplementation Products, Synthetic Bone Substitutes and Others), Application (Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture recovery, Soft Tissue Injuries, and Maxillofacial & Dental Applications), Type (Knee, Ankle, Hip, Wrist & Shoulder, Spine, and Others), and End User (Hospitals & Ambulatory Centers, Research & Academic Institute, and Dental Clinics): Global Opportunity Analysis and Industry Forecast, 2018–2025. The research offers a detailed analysis on changing market dynamics, key investment pockets, major segments, and market competition. According to the report, the global orthobiologics market generated $4.87 billion in 2017 and is projected to reach $6.87 billion by 2025, registering a CAGR of 4.3% from 2018 to 2025.

Download Sample PDF Of Report@ https://www.alliedmarketresearch.com/request-sample/845

Surge in global geriatric population, which is prone to various diseases such as osteoarthritis and others, increase in awareness of orthobiologics, rise in demand for advanced treatment, surge in obesity, and rise in number of sports and road accidents are other factors that drive the growth of the global orthobiologics market. However, higher cost of orthobiologics and stringent approval process restrain the growth of the market. Conversely, high growth potential in developing nations and upsurge in demand for advanced treatment create new opportunities for the market growth.

Key players of the industry:

Leading market players analyzed in the research include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc. These market players have adopted various strategies including collaborations, joint ventures, partnerships, expansions, and others to gain a strong position in the industry.

Viscosupplementation products segment to be lucrative through 2025:-

Among products, the viscosupplementation products segment accounted for half of the overall market share in 2017 and would retain its dominance through 2025. The same would grow at the fastest CAGR of 4.8% during the forecast period. This is due to the increase in geriatric population, rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity.

Hospitals & ambulatory centers segment to be lucrative through 2025:-

Among end users, the hospitals & ambulatory centers segment was the largest in 2017, capturing 90% of the market share and would maintain its dominance through 2025. The same segment would grow at the fastest CAGR of 4.4% from 2018 to 2025. This is because these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.

North America to be dominant, Asia-Pacific to exhibit the fastest growth through 2025:-

North America captured half of the market share in 2017 and is likely to dominate the market through 2025. This is due to rise in the elderly population, favorable reimbursement rates, rise in the prevalence of orthopedic disorders even among younger population, and increase in number of road accidents in the region. However, Asia-Pacific is expected to register the fastest CAGR of 5.7% from 2018 to 2025.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/845

Similar Reports:

Proteomics Market – Global Opportunity Analysis and Industry Forecast, 2018 – 2025

Protein Sequencing Market – Global Opportunity Analysis and Industry Forecast, 2019-2026

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free):

+1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.